Singapore in talks with key suppliers on regional distribution of vaccines

Photo: Bloomberg

Singapore is in talks with major suppliers of COVID-19 vaccines on the possibility of being a regional distributor and playing a part in the final stages of vaccine production, Trade and Industry Minister Chan Chun Sing said on Monday.

Chan, however, did not specify which pharmaceutical firms Singapore was in talks with.

His remarks came a week after Singapore's authorities announced that the country had approved the Pfizer-BioNTech vaccine for use here, with the first shipment set to arrive this month.

We have plans to work with the major suppliers, not so much on the production itself which is done in Europe and the United States but if there's a possibility for us to do what we call fill and finish' to help in the global distribution, TODAY newspaper quoted Chan as saying on the sidelines of a visit to Singapore's Agency for Science, Technology and Research.

Fill and finish refers to the process of filling vials with a vaccine and packaging it for distribution. It is common for vaccine manufacturers to use third parties to fill and package their vaccines.

In his live televised address to the nation last week, Prime Minister Lee Hsien Loong said that several pharmaceutical firms have established vaccine manufacturing capabilities in Singapore.

He added that the government was also supporting vaccine development efforts here as an insurance, in case global supply chains were disrupted.

Singapore has reported a total of 58,432 COVID-19 cases so far with 29 deaths.


(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)


Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Business Standard is now on Telegram.
For insightful reports and views on business, markets, politics and other issues, subscribe to our official Telegram channel